Our research team examined evidence on the nutritional drink Souvenaid, that was claimed to help improve some aspects of memory in people who have Alzheimer's disease.
Our research team examined evidence on the nutritional drink Souvenaid, that was claimed to help improve some aspects of memory in people who have Alzheimer's disease.
...
Glenys Smith, near Bristol, shares the challenges of caring for her husband Ralph who recently moved to a care home. She also shares wellbeing advice for other carers.
Glenys Smith, near Bristol, shares the challenges of caring for her husband Ralph who recently moved to a care home. She also shares wellbeing advice for other carers.
Mild cognitive impairment (MCI) affects many people over the age of 65 and some cases progress to dementia. Find out about our research to provide support for people with MCI.
Phase 2/3 clinical trial results shows early promise for an inhaled insulin spray in people with mild cognitive impairment (MCI) or mild Alzheimer’s disease.
Research from the Systolic Blood Pressure Intervention Trial (SPRINT) shows that treatment to lower blood pressure can reduce Mild Cognitive Impairment (MCI).
There are ways to help a person with mild cognitive impairment manage their symptoms and cope with memory loss. There are strategies that can be adopted to help with this.
Anyone can develop MCI at any age. However, the risk increases greatly as a person gets older. MCI can have a number of different possible causes - some of these are treatable but others are not.
Mild cognitive impairment is when a person starts to have problems with their memory or thinking. It can be a sign of a disease that will eventually cause dementia but MCI is not dementia and can be caused by other health problems.
Dementia Support Line